Giardia lamblia is a frequent pathogen in persistent diarrhoea. Both humoral and cellular immune responses are important in clearing the parasite and providing immunity. A rapid sensitive and specific serological test like dot ELISA could be useful for early detection of Giardia specific serum antibodies for routine diagnosis. This study reports the use of dot ELISA for the detection of Giardia...

Quantum-dot cellular automata (QCA) are a promising nanotechnology to implement digital circuits at the nanoscale. Devices based on QCA have the advantages of faster speed, lower power consumption, and greatly reduced sizes. In this paper, we are presented the circuits, which generate random numbers in QCA.  Random numbers have many uses in science, art, statistics, cryptography, gaming, gambli...

The electronic industry has grown vastly in recent years, and researchers are trying to minimize circuits delay, occupied area and power consumption as much as possible. In this regard, many technologies have been introduced. Quantum Cellular Automata (QCA) is one of the schemes to design nano-scale digital electronic circuits. This technology has high speed and low power consumption, and occup...

Information in a quantum cellular automata architecture is encoded in the polarization state of a cell, i.e. in the occupation numbers of the quantum dots of which the cell is made up. Non-invasive charge detectors of single electrons in a quantum dot are therefore needed, and recent experiments have shown that a quantum constriction electrostatically coupled to the quantum dot may be a viable ...

Quantum-Dot Cellular Automata (QCAs) are becoming more and more one of the most promising candidates for the alternative processing platform of the future. Since their advent in the early 1990s the required technological processes, as well as the QCA structures that implement the basic and functionally complete set of binary logic functions, have been developed. This article, however, presents ...

PURPOSE The Vδ1+ subset of γδ T lymphocytes is a promising candidate for cancer immunotherapy, but the lack of suitable expansion/differentiation methods has precluded therapeutic application. We set out to develop and test (preclinically) a Vδ1+ T-cell-based protocol that is good manufacturing practice compatible and devoid of feeder cells for prompt clinical translation. EXPERIMENTAL DESIGN...